CMRAComera Life Sciences Holdings, Inc.

About Comera Life Sciences Holdings, Inc. (CMRA)

Comera Life Sciences Holdings, Inc. (CMRA) is a Biotechnology company headquartered in Woburn, MA, United States whose shares trade over-the-counter on the Expert Market tier.

Comera is a pre-clinical biotechnology company dedicated to promoting a compassionate new era in medicine. The Company applies a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (“IV”) to subcutaneous (“SQ”) forms. This revolutionary technology provides patients and families with the freedom of self-injectable care, allowing them to realize the potential of these life changing therapies, and to unlock the vast potential of their own lives. To accomplish this, Comera is developing an internal portfolio of proprietary therapeutics that incorporate Comera’s innovative proprietary formulation platform, SQore™. Comera also collaborates with pharmaceutical and biotechnology companies, applying the SQore™ platform to Comera’s partners’ biologic medicines to deliver enhanced formulations that facilitate self-injectable care.

Products and services

Comera is a pre-clinical biotechnology company dedicated to promoting a compassionate new era in medicine. The Company applies a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (“IV”) to subcutaneous (“SQ”) forms. This revolutionary technology provides patients and families with the freedom of self-injectable care, allowing them to realize the potential of these life changing therapies, and to unlock the vast potential of their own lives. To accomplish this, Comera is developing an internal portfolio of proprietary therapeutics that incorporate Comera’s innovative proprietary formulation platform, SQore™. Comera also collaborates with pharmaceutical and biotechnology companies, applying the SQore™ platform to Comera’s partners’ biologic medicines to deliver enhanced formulations that facilitate self-injectable care.

CMRA key facts

Ticker symbol

CMRA

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Woburn, MA, United States

Country of incorporation

US

Year of incorporation

2022

Employees

8

Estimated market cap

$6.1K (as of Apr 16, 2025)

Shares outstanding

30,737,796

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Jan 26, 2024)

Comera Life Sciences Holdings, Inc. leadership

• Michael Campbell — CEO, CFO, Principal Executive Officer, Principal Fin. Officer
• Jim Buckley — Finance Manager

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with C